L26/O-273 Factors influencing embryonic development in GnRH Agonist-trigger only cycles: a mixed-effects retrospective analysis
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A. Arnanz und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Study question To identify parameters that are associated with post-insemination outcomes in GnRH agonist-trigger only cycles. Summary answer Higher trigger estradiol (E2), lower progesterone (P4) per mature follicle are negatively associated with embryo quality; age remains the only euploid predictor in agonist-trigger cycles. What is known already The choice of final oocyte maturation trigger is crucial for oocyte recovery and embryo quality. It has been demonstrated that the use of GnRH agonist trigger only for high responders decrease the risk of ovarian hyperstimulation syndrome (OHSS). However, the independent effects of agonist triggering on embryo outcomes remain incompletely understood. Oocyte maturation has already been debated, but very little is known about subsequent embryo development. The purpose of this study is to address gaps in embryo outcomes post agonist trigger. Study design, size, duration A retrospective cohort analysis of 481 GnRH agonist-trigger only IVF cycles in high responder patients (identified by elevated AHM values and high oocyte yield) was performed between 2015–2024 in a tertiary referral center. Patients with double trigger and hCG-only trigger were excluded. The most common gonadotropin regimen was FSH (58.2%) followed by hMG activity (30.1%). Participants/materials, setting, methods The primary endpoints were low maturation rate (≤first quartile maturation rate), top/good quality (Gardner grading AA/AB/BA/BB Day 5–6), and chromosomal euploid status (preimplantation genetic testing). The predictor variables were female age, body mass index (BMI), serum anti-Müllerian hormone (AMH), basal follicle-stimulating hormone/luteinizing hormone, stimulation duration, gonadotropin-releasing hormone antagonist cumulative dose, and trigger-day E2/P4 per mature follicle (>10 mm). Mixed-effects logistic regression models with random intercepts accounted for embryo clustering. Log2 transformation applied to hormonal variables. Main results and the role of chance A total of 8.931 embryos from 433 patients were analyzed. On trigger day, median estradiol was 3.000pg/ml (2.459-4.323), progesterone 0.79ng/ml (0.58-1.06) and follicle count was 29 (24-35). Mean maternal age was 31.1±5.5 years, BMI was 26.3±4.6 kg/m2 and median AMH 5.09ng/ml (3.48-7.45). Oocyte maturation was 79.2% (IQR: 68–88.9%], fertilization 76.2%, blastulation 77.8%, and euploidy 60.0% rate. No cycle parameters significantly predicted low maturation (IQR1 < 68%). Age, BMI, AMH, stimulation days, and antagonist dose were not independently associated with outcomes after adjustment. Higher trigger E2 value per follicle was negatively associated with top/good quality (aOR 0.76 per doubling, p = 0.020), while higher trigger P4 value per follicle was positively associated (aOR 1.20 per doubling, p = 0.040). Maternal age was the only independent predictor for euploidy; each additional year reduced odds of euploidy (aOR 0.93, p < 0.001). Limitations, reasons for caution This retrospective single-center analysis limits external validity; heterogeneous undifferentiated cohort prevents diagnosis-specific analysis. Exploratory trigger hormone findings require prospective validation in independent populations. Wider implications of the findings In GnRH agonist–trigger only cycles, trigger-day endocrine balance appears relevant for embryo quality, suggesting potential value in individualized trigger assessment, but female age remains the dominant determinant of euploidy. Trial registration number No
Zitieren
APA
Arnanz, A., Peralta, S., Salame, A., Dadir, H., Gallego, R. D., Nogueira, D., Bayram, A., Ibrahim, E., & Fatemi, H. (2026). L26/O-273 Factors influencing embryonic development in GnRH Agonist-trigger only cycles: a mixed-effects retrospective analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.271
Vancouver
Arnanz A, Peralta S, Salame A, Dadir H, Gallego RD, Nogueira D, et al. L26/O-273 Factors influencing embryonic development in GnRH Agonist-trigger only cycles: a mixed-effects retrospective analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.271
BibTeX
@article{Arnanz2026,
author = {Arnanz, A. and Peralta, S. and Salame, A. and Dadir, H. and Gallego, R. Del and Nogueira, D. and Bayram, A. and Ibrahim, E. and Fatemi, H.},
title = {L26/O-273 Factors influencing embryonic development in GnRH Agonist-trigger only cycles: a mixed-effects retrospective analysis},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.271}
}
EUVIMED